Category: Alzheimers / Dementia

Tacrine is a centrally acting acetylcholinesterase inhibitor and indirect cholinergic agonist (parasympathomimetic). It was the first centrally acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. Tacrine was first synthesised by Adrien Albert at the University of Sydney in 1949. It also acts as a histamine N-methyltransferase inhibitor.[1] Contents 1 Clinical use 2 Adverse Effects 2.1 Overdose 3 ... [wikipedia]

Related Brands

Drugs with the same active ingredients